Virax Biolabs, is a company developing a game-changing immunology platform based around T-Cell testing called Virax Immune. The recent pandemic and ongoing ‘tripledemic’ have made the public more aware of viral threats while raising curiosity of one’s own susceptibility to these threats. Virax Immune is a proprietary T cell testing platform to determine whether an individual will be able to mount a robust response to an infection. T cell tests are more informative than antibody and antigen testing as T cells provide long-term immunity to pathogenic threats. With a better understanding of immune status and consultation of a physician, patients will be equipped with information to make personalized proactive and protective decisions rather than a one-size-fits-all and reactionary approach that was evident in the global management of Covid-19.
DocWire News spoke with with Tomasz George, Chief Scientific Officer at Virax Labs, to learn more about this innovaive company and its platform.